Arteris Inc (AIP)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Arteris Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 26 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 29.90 $ — 53% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
Sells AIArteris lizenziert Network-on-Chip-Verbindungstechnik (NoC) ausdrücklich auch für KI-Chips: Der Geschäftsbericht (10-K) nennt KI/Machine Learning als Endmarkt des Lizenz- und Royalty-Umsatzes, beschreibt KI als Beschleuniger des NoC-Geschäfts, das Produkt FlexGen arbeitet mit KI-gestützter Automatisierung — und die Filings warnen, dass Exportkontrollen auf KI-Chipdesigner in China den eigenen Umsatz senken können.
View the full file — quotes, sources, reviewed filings
„Artificial Intelligence (AI) and Generative AI are transforming the semiconductor industry, revolutionizing how our customers approach design, development, and the resulting products. The rapid expansion of AI applications across various industries, combined with the increasing complexity of electronic system design, is accelerating the use of network-on-chip technologies."
Künstliche Intelligenz (KI) und generative KI transformieren die Halbleiterindustrie und revolutionieren, wie unsere Kunden Design, Entwicklung und die daraus entstehenden Produkte angehen. Die rasche Ausbreitung von KI-Anwendungen über verschiedenste Branchen hinweg beschleunigt — zusammen mit der wachsenden Komplexität des Elektronik-Designs — den Einsatz von Network-on-Chip-Technologien.
„Demand for our interconnect IP solutions and associated royalty revenue is highly dependent on market conditions in the end markets in which our customers operate. These end markets, which include the automotive, enterprise computing, communications, artificial intelligence and machine learning, consumer electronics, and industrial markets, are subject to a number of factors including end-product acceptance and sales, competitive pressures, supply chain issues and general market conditions."
Die Nachfrage nach unseren Interconnect-IP-Lösungen und der zugehörige Royalty-Umsatz hängen stark von den Marktbedingungen in den Endmärkten unserer Kunden ab. Zu diesen Endmärkten zählen Automobil, Enterprise Computing, Kommunikation, künstliche Intelligenz und Machine Learning, Unterhaltungselektronik und Industrie; sie unterliegen einer Reihe von Faktoren, darunter Akzeptanz und Absatz der Endprodukte, Wettbewerbsdruck, Lieferkettenprobleme und allgemeine Marktbedingungen.
„Supported by AI-driven automation, FlexGen reduces manual iteration providing expert-level NoC topologies, while reducing wire-length and power which are critical to advance node designs and becoming increasingly valued."
Gestützt auf KI-getriebene Automatisierung reduziert FlexGen manuelle Iterationen und liefert Network-on-Chip-Topologien auf Expertenniveau — bei geringerer Leitungslänge und geringerem Stromverbrauch, was für Designs auf modernsten Fertigungsprozessen entscheidend ist und zunehmend geschätzt wird.
„U.S. export regulations […] may limit or adversely impact our ability to license or support our products to entities in or doing business with certain advanced AI or “supercomputer” design companies, foundries and manufacturers of assemblies and components in China. As a result of these restrictions, our customers may experience changes to or delays in their design projects, and we may face challenges to maintain our revenue and/or our revenue may decrease."
US-Exportvorschriften […] können unsere Möglichkeiten einschränken oder beeinträchtigen, unsere Produkte an Unternehmen zu lizenzieren oder zu supporten, die zu bestimmten Entwicklern fortgeschrittener KI- oder „Supercomputer“-Chips, Auftragsfertigern sowie Herstellern von Baugruppen und Komponenten in China gehören oder mit ihnen Geschäfte machen. Infolge dieser Beschränkungen kann es bei unseren Kunden zu Änderungen oder Verzögerungen ihrer Design-Projekte kommen, und es kann uns schwerfallen, unseren Umsatz zu halten — beziehungsweise unser Umsatz kann sinken.
Filings Reviewed: 10-Q 2026-05-12 · 10-Q 2025-11-04 · 10-Q 2025-08-05 · 10-Q 2025-05-13 · 10-K 2026-02-12 · 10-K 2025-02-18
Rated on July 10, 2026 · How the Rating Is Built
Growth Score
6 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 11.9% failed
- More than 10% revenue growth is expected for the coming year 20.3% passed
- Share count grows by less than 3% a year 9.1% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 29.8% failed
- Gross margin at 40% or higher and without meaningful erosion 90.2% passed
- Goodwill from acquisitions does not grow faster than revenue 3.6% passed
- Net debt below twice EBITDA 46 m net cash passed
- Operating cash flow covers the profits of the last three years 96 m passed
- Return on capital at 15% or higher, or up versus two years ago -79.2% failed
- Insiders hold at least 10% or are net buyers 25.5% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 27.8% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 4
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.10 | -0.16 – -0.07 | 95 | 69.1% | 5 |
| 12/31/2027 | 0.16 | 0.13 – 0.20 | 115 | 254.4% | 4 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.17 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.20 | – | 16 | 23.90 | -53.00 | -3 | -3 |
| 2025: Q1 | -0.20 | – | 17 | 27.70 | -49.10 | 3 | 3 |
| 2025: Q2 | -0.22 | – | 17 | 13.20 | -55.30 | -3 | -3 |
| 2025: Q3 | -0.21 | – | 17 | 18.30 | -51.60 | 3 | 3 |
| 2025: Q4 | -0.19 | – | 20 | 30.00 | -42.20 | 3 | 3 |
| 2026: Q1 | -0.17 | – | 23 | 38.70 | -34.70 | -7 | -7 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2019 | 32 | 7 | 6 | 0.26 | 12 | -4 | 27 |
| 2020 | 32 | -4 | -3 | -0.10 | 2 | -6 | 43 |
| 2021 | 38 | -22 | -23 | -1.06 | -1 | 53 | 120 |
| 2022 | 50 | -29 | -27 | -0.84 | -7 | 38 | 116 |
| 2023 | 54 | -35 | -37 | -1.03 | -16 | 15 | 103 |
| 2024 | 58 | -32 | -34 | -0.86 | -1 | -1 | 106 |
| 2025 | 71 | -33 | -35 | -0.82 | 7 | -15 | 115 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Arteris, Inc. bietet zusammen mit seinen Tochtergesellschaften Halbleiter-System-IP-Lösungen (geistiges Eigentum) in den USA, im übrigen Amerika, in China, Korea, im übrigen asiatisch-pazifischen Raum, in Europa und im Nahen Osten an.
| Employees | 353 |
|---|---|
| Headquarters | Campbell, CA |
| Address | 900 E. Hamilton Avenue, 95008 Campbell, United States |
| Phone | 408 470 7300 |
| Website | arteris.com |
| IPO Date | 27. Oct 2021 |
| ISIN | US04302A1043 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Karel Charles Janac | Chairman, CEO & President | 1959 |
| Nicholas Bryan Hawkins FCA | Executive VP & CFO | 1962 |
| Laurent R. Moll | Executive VP of Engineering & COO | 1972 |
| Paul L. Alpern | Executive VP, Chief Legal Officer & Corporate Secretary | 1965 |
| Michal Siwinski | EVP and Chief Product & Marketing Officer | – |
| Ken Way | Executive VP of Sales & Chief Customer Officer | – |
| Jolene Bishop | Executive VP & Chief Human Resources Officer | – |
| Evin Arici Kebebew | Corporate Controller | 1985 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 6. Jul 2026 | Bayview Legacy, LLC | 10% Owner | Sell | 68,578 | 35.07 | 2,404,688 |
| 6. Jul 2026 | Bayview Legacy, LLC | 10% Owner | Sell | 27,908 | 36.24 | 1,011,288 |
| 6. Jul 2026 | Bayview Legacy, LLC | 10% Owner | Sell | 29,490 | 37.07 | 1,093,209 |
| 6. Jul 2026 | Alpern Paul L | VP and General Counsel | Sell | 2,878 | 35.11 | 101,051 |
| 6. Jul 2026 | Alpern Paul L | VP and General Counsel | Sell | 1,301 | 35.98 | 46,812 |
| 6. Jul 2026 | Alpern Paul L | VP and General Counsel | Sell | 1,824 | 37.13 | 67,724 |
| 6. Jul 2026 | Janac K Charles | President and CEO | Sell | 68,578 | 35.07 | 2,404,688 |
| 6. Jul 2026 | Janac K Charles | President and CEO | Sell | 27,908 | 36.24 | 1,011,288 |
| 6. Jul 2026 | Janac K Charles | President and CEO | Sell | 29,490 | 37.07 | 1,093,209 |
| 6. Jul 2026 | Janac K Charles | President and CEO | Sell | 2,908 | 37.12 | 107,939 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.